JALUPRO® YOUNG EYE

JALUPRO® YOUNG EYE is an advanced injectable treatment designed specifically for the periorbital area, addressing early signs of aging such as under-eye dark circles, fine lines, and skin laxity. This product is part of the Jalupro family of dermal biorevitalizers and offers a powerful combination of hyaluronic acid and amino acids to hydrate, restructure, and brighten delicate eye-area skin.

It is specially formulated to target thin, fragile, or crepey skin in the upper and lower eyelid regions. JALUPRO® YOUNG EYE helps to improve tissue quality, elasticity, and volume, producing visible results within weeks. Its targeted action makes it a first-line choice for rejuvenating the eye contour area in patients with visible signs of aging or fatigue.

JALUPRO® YOUNG EYE is administered via intradermal microinjections in the periorbital region using a fine needle or cannula. Treatments typically consist of a three-session protocol, spaced 10 days apart, for optimal dermal biostimulation and aesthetic improvement.

• Treatment schedule: 3 sessions

• Interval: Every 10 days

• Injection technique: Microinjections or linear retrograde technique

• Needle recommendation: 30G or 32G x 4–6 mm

• Volume per session: 0.2–0.4 mL per side

• Injection plane: Superficial or mid dermis

• Post-care: Gentle cooling, avoid rubbing treated area for 24 hours

JALUPRO® YOUNG EYE is indicated for aesthetic correction and rejuvenation of the periorbital and eyelid areas in patients exhibiting early signs of aging. It is ideal for patients looking to reduce under-eye darkness, dryness, or fine wrinkles in a safe and non-volumizing way.

Indications:

• Periorbital wrinkles and under-eye lines

• Dark circles and tired-looking eyes

• Loss of skin tone, brightness, or firmness around the eyes

• Laxity in upper or lower eyelids

Contraindications:

• Pregnant or breastfeeding women

• Patients with active skin infection, eczema, or inflammation near injection site

• Known allergies to hyaluronic acid or amino acids

• Autoimmune disorders or immunocompromised states

Side Effects:

• Temporary redness, swelling, or mild bruising at injection site

• Rare cases of itching or lumpiness

• Very rare: Allergic reaction or granuloma formation

JALUPRO® YOUNG EYE contains a potent mix of non-crosslinked hyaluronic acid and essential amino acids that stimulate fibroblast activity, aiding in collagen production and tissue repair.

• Hyaluronic acid: 1.1 mg/mL (non-crosslinked, biocompatible)

• Amino acids: Glycine, L-Proline, L-Leucine, L-Lysine

• pH-balanced, sterile solution for injection

• No BDDE or cross-linking chemicals used

These ingredients support hydration, cellular metabolism, and dermal remodeling, particularly in fragile and movement-prone skin around the eyes.

The product is delivered in sterile, single-use packaging for professional use. It includes both the injectable solution and sterile accessories for application.

• 1 glass vial containing 1.0 mL of product

• Sterile packaging for injection

• Product insert/instructions for use

• Intended for single-patient use only

• Does not include needle or syringe (to be selected by practitioner)

Side effects are typically mild and transient, associated mainly with the injection process. The formulation’s non-crosslinked HA and absence of BDDE help minimize inflammation or adverse immune responses.

• Common: Redness, swelling, pinpoint bruising

• Mild tenderness or itching in the treated area

• Rare: Minor nodules or firmness at injection site

• Very rare: Hypersensitivity or allergic reaction

• Symptoms usually resolve within 24–72 hours

To preserve the product’s stability and efficacy, proper cold storage is essential. JALUPRO® YOUNG EYE should be kept under controlled conditions and protected from extreme temperatures.

• Storage temperature: 2°C to 25°C

• Do not freeze

• Keep in original packaging until use

• Protect from light and heat

• Use by expiry date indicated on box/vial